{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:40:34Z","timestamp":1791567634398,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejmech.2022.114996","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:49:57Z","timestamp":1670546997000},"page":"114996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents"],"prefix":"10.1016","volume":"246","author":[{"given":"Jhajan","family":"Lal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabina B.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanshi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9762-9160","authenticated-orcid":false,"given":"Damodara N.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114996_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114996_bib3","first-page":"1","article-title":"Research priorities for chagas disease, human AfricanTrypanosomiasis and leishmaniasis","volume":"975","year":"2012","journal-title":"World Health Organ. Technol. Rep. Ser."},{"key":"10.1016\/j.ejmech.2022.114996_bib4","first-page":"69","article-title":"Review of the current treatments for leishmaniases","volume":"3","author":"Lauletta","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.ejmech.2022.114996_bib5","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2022.114996_bib6","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.2174\/0929867325666180426164352","article-title":"Current and future prospects of nitro-compounds as drugs for trypanosomiasis and leishmaniasis","volume":"26","author":"Patterson","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/D0MD00083C","article-title":"Antileishmanial assessment of isoxazole derivatives against","volume":"11","author":"Mukhopadhyay","year":"2020","journal-title":"L. donovani. RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113516","article-title":"Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents","volume":"221","author":"Mishra","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib9","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1021\/acs.jmedchem.5b01456","article-title":"Novel amino-pyrazole ureas with potent in vitro and in vivo antileishmanial activity","volume":"58","author":"Mowbray","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.jmedchem.6b01447","article-title":"Antileishmanial activity of pyrazolopyridine derivatives and their potential as an adjunct therapy with miltefosine","volume":"60","author":"Anand","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2004.01.009","article-title":"Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents","volume":"39","author":"Mayence","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib12","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1021\/jm3007596","article-title":"Salicylanilide inhibitors of Toxoplasma gondii","volume":"55","author":"Fomovska","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bmc.2012.10.056","article-title":"Structure\u2013activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling","volume":"21","author":"Lee","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib14","doi-asserted-by":"crossref","unstructured":"J. Lal, G. Kaul, A. Akhir, S. B. Ansari, S. Chopra, D. N. Reddy, Bio-evaluation of fluoro and trifluoromethyl-substituted salicylanilides against multidrug-resistant S. aureus. Med. Chem. Res. 30 (2021), 2301-2315. https:\/\/doi.org\/10.1007\/s00044-021-02808-4.","DOI":"10.1007\/s00044-021-02808-4"},{"key":"10.1016\/j.ejmech.2022.114996_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.5606\/ArchRheumatol.2019.7100","article-title":"The anti-rheumatoid activity of niclosamide in collagen-induced arthritis in rats","volume":"34","author":"Al-Gareeb","year":"2019","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.ejmech.2022.114996_bib16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.21873\/anticanres.14082","article-title":"Antihelminthic niclosamide induces autophagy and delayed apoptosis in human non-small lung cancer cells in vitro and in vivo","volume":"40","author":"Chai","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2022.114996_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad spectrum antiviral agent niclosamide and its therapeutic potential","volume":"6","author":"Xu","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114996_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114996_bib20","doi-asserted-by":"crossref","first-page":"3e25","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2022.114996_bib21","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"12","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib22","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114996_bib23","article-title":"OSIRIS property explorer","author":"Sander","year":"2001","journal-title":"Organic Chemistry Portal"},{"key":"10.1016\/j.ejmech.2022.114996_bib24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/chem.202003135","article-title":"The role of fluorine in glycomimetic drug design","volume":"27","author":"Hevey","year":"2021","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2022.114996_bib25","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1021\/acsomega.0c00830","article-title":"Contribution of organofluorine compounds to pharmaceuticals","volume":"5","author":"Inoue","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2022.114996_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114996_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2018.05.014","article-title":"Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents","volume":"154","author":"Upadhyay","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422008984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422008984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:22Z","timestamp":1759330282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422008984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"alternative-id":["S0223523422008984"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114996","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114996"}}